These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 19770650

  • 1. Growth hormone and bone.
    Tritos NA, Biller BM.
    Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):415-22. PubMed ID: 19770650
    [Abstract] [Full Text] [Related]

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 3. GH deficiency in the adult and bone.
    Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A.
    J Endocrinol Invest; 2005 Nov; 28(8 Suppl):18-23. PubMed ID: 16323825
    [Abstract] [Full Text] [Related]

  • 4. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 5. [Hormones and osteoporosis update. Growth hormone and bone].
    Tanaka H.
    Clin Calcium; 2009 Jul; 19(7):984-9. PubMed ID: 19567995
    [Abstract] [Full Text] [Related]

  • 6. Skeletal consequences of discontinuation of growth hormone at final height.
    Drake WM, Carroll PV, Savage MO, Monson JP.
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1351-4. PubMed ID: 12510990
    [Abstract] [Full Text] [Related]

  • 7. Is the somatopause an indication for growth hormone replacement?
    Savine R, Sönksen PH.
    J Endocrinol Invest; 1999 Dec; 22(5 Suppl):142-9. PubMed ID: 10442584
    [Abstract] [Full Text] [Related]

  • 8. Transition of childhood-onset growth hormone-deficient patients to adult healthcare.
    Rapaport R, Cook DM.
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():82-90. PubMed ID: 17261975
    [Abstract] [Full Text] [Related]

  • 9. Somatopause: dismetabolic and bone effects.
    Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC, Colao A.
    J Endocrinol Invest; 2005 Dec; 28(10 Suppl):36-42. PubMed ID: 16550721
    [Abstract] [Full Text] [Related]

  • 10. Regulation of bone mass by growth hormone.
    Olney RC.
    Med Pediatr Oncol; 2003 Sep; 41(3):228-34. PubMed ID: 12868124
    [Abstract] [Full Text] [Related]

  • 11. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 12. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
    Christ ER, Carroll PV, Russell-Jones DL, Sönksen PH.
    Schweiz Med Wochenschr; 1997 Aug 30; 127(35):1440-9. PubMed ID: 9297747
    [Abstract] [Full Text] [Related]

  • 13. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 30; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 14. The role for growth hormone in linking arthritis, osteoporosis, and body composition.
    Tauchmanova L, Di Somma C, Rusciano A, Lombardi G, Colao A.
    J Endocrinol Invest; 2007 Aug 30; 30(6 Suppl):35-41. PubMed ID: 17721072
    [Abstract] [Full Text] [Related]

  • 15. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S, Dalle Carbonare L, Albiger N, Scanarini M, Bilora F, Petrobelli F, Giannini S, Mantero F, Scaroni C.
    Horm Metab Res; 2006 Jan 30; 38(1):16-21. PubMed ID: 16477535
    [Abstract] [Full Text] [Related]

  • 16. Effect of GH treatment on bone mass in children with GH deficiency.
    Baroncelli GI, Saggese G.
    J Endocrinol Invest; 2005 Jan 30; 28(10 Suppl):23-7. PubMed ID: 16550718
    [Abstract] [Full Text] [Related]

  • 17. Treatment of the adult growth hormone deficiency syndrome: directions for future research.
    Hoffman AR.
    Growth Horm IGF Res; 2005 Jul 30; 15 Suppl A():48-52. PubMed ID: 16039888
    [Abstract] [Full Text] [Related]

  • 18. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan 30; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact.
    Mukherjee A, Shalet SM.
    Med Pediatr Oncol; 2003 Sep 30; 41(3):235-42. PubMed ID: 12868125
    [Abstract] [Full Text] [Related]

  • 20. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.
    Growth Horm IGF Res; 2005 Jun 30; 15(3):231-7. PubMed ID: 15921942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.